Rapid Micro Biosystems, INC.
Identifying microbial contaminants in manufacture of drugs, medical devices, etc.
Based in MA
🤖
AI Overview
With $220K in lobbying spend across 9 quarterly filings, Rapid Micro Biosystems, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2019 to 2021.
$220K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $50K |
| 2020 | $120K |
| 2021 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Science/Technology
- •Development of improved technology to identify microbial contaminants in manufacture of drugs, medical devices and personal care products to insure public health and safety.
- •Adoption of advanced technology to identify microbiological contaminants to insure patient health and safety.
- •FDA funding to support GMP enforcement of regulated manufacturing facilities.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.